News

To initiate the production, Zydus Nycomed will manufacture Pantoprazole, Urapidil and Lornoxicam. Further, the company will produce eight additional APIs by 2011. Zydus Nycomed claims that the plant

UMN-0501 is a cell culture based H5N1 avian influenza vaccine, currently under preparation for Phase III clinical trial in Japan. UMN-0502 is a cell culture based seasonal influenza

The new polymer-based technology represents a practical way to integrate the use of NO into a variety of wound healing products, which could include granulated and powder dressings,

The Preflucel vaccine was shown to be effective in preventing seasonal influenza and is indicated for prophylaxis of influenza in adults and the elderly, the company said. According

The mouth rinse products include J&J’s Listerine Total Care Anticavity Mouthwash, CVS Complete Care Anticavity Mouthwash and Walgreen Mouth Rinse Full Action. The claims suggest that the products

Bakali will be responsible for Marketing and Sales, Corporate and Business Development, and Alliance Management of the company. Bakali will also play a key role with the other

Under the contract, HKPI-JV is expected to support the bio pharmaceutical companies to commercialise therapies in Egypt by recruiting, training and placing pharmaceutical sales representatives; forming and managing

The latest agreement follows on the agreement entered in February 2010, in which Starpharma stated that its dendrimer drug delivery technology will be applied to enhance compounds in

The data demonstrated low rates of target lesion revascularisation (TLR) and side branch failure (3.6 and 1.2%, respectively), with no incidences of stent thromboses. Tryton Medical president and